2013
DOI: 10.1186/1755-8794-6-s3-s4
|View full text |Cite
|
Sign up to set email alerts
|

Inferring drug-disease associations from integration of chemical, genomic and phenotype data using network propagation

Abstract: BackgroundDuring the last few years, the knowledge of drug, disease phenotype and protein has been rapidly accumulated and more and more scientists have been drawn the attention to inferring drug-disease associations by computational method. Development of an integrated approach for systematic discovering drug-disease associations by those informational data is an important issue.MethodsWe combine three different networks of drug, genomic and disease phenotype and assign the weights to the edges from available… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
31
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 51 publications
(31 citation statements)
references
References 74 publications
(82 reference statements)
0
31
0
Order By: Relevance
“…For many specific diseases, that data set is unknown, or incomplete, which makes the use of the methods more difficult. To overcome this, Huang et al [143] proposed a completely unsupervised integrative method that can infer drug-disease associations without any prior associations. They used coupled network propagation [161] on drug-drug chemical similarity, diseasedisease phenotype similarity and gene-gene co-expression similarity homogeneous networks, connected by drug-gene and gene-disease heterogeneous networks.…”
Section: Computational Methods For Drug Repurposing and Personalised mentioning
confidence: 99%
See 1 more Smart Citation
“…For many specific diseases, that data set is unknown, or incomplete, which makes the use of the methods more difficult. To overcome this, Huang et al [143] proposed a completely unsupervised integrative method that can infer drug-disease associations without any prior associations. They used coupled network propagation [161] on drug-drug chemical similarity, diseasedisease phenotype similarity and gene-gene co-expression similarity homogeneous networks, connected by drug-gene and gene-disease heterogeneous networks.…”
Section: Computational Methods For Drug Repurposing and Personalised mentioning
confidence: 99%
“…Coupled network propagation [143] Drug-disease network inference by integrating drug, disease and gene interaction network, as well as drug-gene and gene-disease association network.…”
Section: Databasementioning
confidence: 99%
“…They simultaneously explore the structure of each network and of their mutual relations; based on all this information, they create an integrated inference. Such approaches, also called network propagation methods, have been applied to biological problems, including genedisease prioritization [69,72], drug-target prediction, drug repurposing [70,71] and drug-disease association prediction [73]. Although these approaches are mainly designed for a pair of inter-related networks, their further extensions to handle more networks are possible.…”
Section: Network-based Methodsmentioning
confidence: 99%
“…Although these approaches are mainly designed for a pair of inter-related networks, their further extensions to handle more networks are possible. For example, Huang et al [73] extended the network propagation method to three interrelated networks. However, with the inclusion of multiple networks, the number of coupled iterative equations for information propagation (diffusion) grows and hence, the running time of the algorithm increases.…”
Section: Network-based Methodsmentioning
confidence: 99%
“…Network topology can be utilized in graph-based algorithms such as label propagation methods 141 that iteratively propagate information to neighboring nodes; network-based inference 23 methods that make new connections based only on local topology; and shortest-path algorithms to identify parsimonious explanations of network perturbations 142 .…”
Section: Data Integration In Computational Pharmacologymentioning
confidence: 99%